BIOmarker-guided Study to Evaluate the Efficacy and Safety of cemipLimab for advancEd Cutaneous T-cell Lymphoma

Condition:   Mycosis Fungoides Intervention:   Drug: Cemiplimab Sponsor:   AHS Cancer Control Alberta Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials